Adipokinetic Hormone (AKH) (24-32), locust is a peptide hormone isolated from locusts.
Adipokinetic Hormone (AKH) (24-32), locust, is a specialized peptide fragment derived from the full-length adipokinetic hormone sequence found in locust species. As a member of the AKH peptide family, it plays a pivotal role in regulating energy mobilization during periods of high metabolic demand in insects. The (24-32) fragment represents a specific region of the peptide that has attracted interest for its functional activity, structural properties, and potential to elucidate the mechanisms underlying insect metabolic processes. Its biochemical relevance extends to studies of peptide-receptor interactions, conformational analysis, and the broader investigation of insect endocrinology.
Peptide signaling research: The AKH (24-32) fragment is widely employed to investigate the mechanisms of neuropeptide signaling in insects. By focusing on this specific sequence, researchers can dissect the structural requirements for receptor binding and activation, enabling a deeper understanding of how truncated peptides interact with their cognate G protein-coupled receptors. Such studies contribute to mapping the minimal bioactive motifs necessary for physiological activity, providing valuable insights into the evolution and diversification of insect hormone systems.
Metabolic regulation studies: In the context of insect physiology, this peptide fragment serves as a tool to probe the regulation of lipid and carbohydrate mobilization. Experimental application of the (24-32) sequence allows scientists to assess its efficacy in stimulating the release of stored energy substrates from the fat body, a process critical during flight or starvation. These investigations help clarify the structure-activity relationships that govern metabolic control in locusts and related species, informing broader models of energy balance in arthropods.
Peptide-receptor interaction assays: The locust AKH (24-32) peptide is frequently utilized in binding and activation assays to characterize the specificity and affinity of insect adipokinetic hormone receptors. By employing radiolabeled or fluorescently tagged variants, researchers can quantitatively analyze receptor-ligand interactions, assess competitive binding with endogenous peptides, and delineate the receptor's pharmacological profile. These studies support the rational design of peptide analogs with tailored biological activity for fundamental or applied insect science.
Synthetic peptide benchmarking: As a defined peptide fragment, AKH (24-32) is valuable in benchmarking the performance of synthetic peptide synthesis protocols. Its relatively short and well-characterized sequence makes it suitable for optimizing solid-phase peptide synthesis, purification strategies, and analytical quality control methods such as mass spectrometry or HPLC. Such benchmarking is essential for ensuring reproducibility and reliability in peptide production workflows across research and industrial laboratories.
Comparative endocrinology: The use of this peptide fragment extends to comparative studies aimed at understanding hormone evolution and functional divergence among insect species. By analyzing the activity and receptor interactions of the locust-derived sequence in different insect models, researchers can uncover conserved and divergent features of AKH signaling pathways. These comparative approaches provide a foundation for evolutionary biology investigations and may inform the development of novel strategies for pest management based on endocrine disruption.
2. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More